Clinical Trials Logo

Intellectual Disability clinical trials

View clinical trials related to Intellectual Disability.

Filter by:

NCT ID: NCT03218462 Completed - Clinical trials for Intellectual Disability

Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

Children with intellectual/developmental disabilities (ID/DD) will experience less dental anxiety and cooperate better in a Sensory Adapted Dental Environment (modified visual, sensory, and somatosensory stimuli in a regular dental setting) than in a regular dental environment (RDE).

NCT ID: NCT03212092 Completed - Clinical trials for Intellectual Disability

Reducing Aggression Among People With an Intellectual Disability

PSYVB
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The study is an randomised controlled trial (RCT) to test whether supplementation of vitamins, minerals and n-3 fatty acids may reduce aggressive behavior in people with intellectual disabilities.

NCT ID: NCT03203226 Completed - Clinical trials for Intellectual Disability

The Feldenkrais Method for People With Intellectual Disability

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Loss of functioning and age-related health problems tend to appear earlier in individuals with intellectual disability (ID) than in their non-disabled peers and due to this people with ID who are in employment tend to need to retire earlier, producing social, economic and health problems. The Feldenkrais method (FM) is a movement-based form of learning that enhances body balance and physical functioning. We hypothesized that the FM could be helpful to improve balance and functioning of employed people with ID.

NCT ID: NCT03139760 Completed - Weight Loss Clinical Trials

POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability

POWERSforID
Start date: September 2016
Phase: N/A
Study type: Interventional

POWERSforID is a 24 week randomized control trial designed to assess the feasibility of a telehealth and coaching intervention for improving health outcomes of adults with intellectual disability. Recruitment is conducted through a disability health clinic located in Colorado Springs, CO.

NCT ID: NCT03135236 Completed - Down Syndrome Clinical Trials

Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome

Start date: March 6, 2017
Phase: N/A
Study type: Interventional

By integrating sexuality and disability literatures, theories, and research methodologies, this study aims to: 1) contribute to the limited knowledge professionals have of parents as the primary sexuality educators; 2) create a resource for parents in order to be sexuality educators for their young adults with I/DD; and 3) evaluate the effectiveness of the Home B.A.S.E. for Developmental Disabilities Curriculum. In order to meet the objectives the study seeks to answer the following questions: 1. What is the effectiveness of a sexuality education workshop for parents of young adults with DS on improving the self-efficacy and attitudes around sexuality and healthy relationships for young adults with DS as well as increase the parent-child communication on sexuality topics? 2. What are parents' concerns that impact their ability to be the primary sexuality educators for their young adults with DS? It is proposed that parent confidence and comfort talking about sexuality topics with their young adult with Down syndrome will increase thereby increasing the parent-child communication as a result of this study.

NCT ID: NCT03088007 Completed - Clinical trials for Disability, Intellectual

Importance of Multidimensional Assessments in Accompanying Schooling of Children With Mild to Moderate Intellectual Disability.

EVAL'ID
Start date: August 1, 2014
Phase: N/A
Study type: Observational

The EVAL'ID study aims to demonstrate the value of a multidimensional assessment in accompanying schooling of children with Intellectual Disability. The study will be performed in the Rhône department (France) in children aged from 5 to 13 years with mild to moderate Intellectual Disability , and attending school either at ULIS (Unités Localisées pour l'Inclusion Scolaire, which enables disabled children to attend regular schools), or IME (Instituts Médico-Educatifs, which are special schools mandated to accommodate children and young people with Intellectual Disability at any level of disability). A multidimensional assessment encompasses the assessment of academic, cognitive, behavioral and adaptive skills of the children, with validated and reliable neuropsychological batteries, called ID Kit (Intellectual Deficiency assessment Kit), which includes the following scales : the Wechsler Intelligence Scale for Children 4th edition (WISC-IV), the Vineland Adaptive Behavioral Scale II, the GECEN rating form (Grille d'Evaluation Comportementale pour Enfants Nisonger, which is the French translation of the Nisonger Child Behavior Rating Form), and an academic skills rating form (GEVA-SCO). A comparison of the children neuropsychological profiles according to the type of school they attend, will be perform. The project consists of three phases: - Stage 1: Collection of information from each child records at MDPH (Departmental Administration for Disabled Persons), IME, ULIS schools, including the assessments that were performed, and from a survey of both caregivers and parents regarding their respective perception and knowledge of the child's disability - Stage 2: All the children who were not previously assessed with the ID kit will be further evaluated using these tests. The results of these assessments will be shared with parents and caregivers. - Stage 3: A survey regarding the perception and knowledge of the child's disability will be carried out again among caregivers and parents.

NCT ID: NCT03040609 Completed - Clinical trials for Profound Multiple Intellectual Disabilities

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)

PLH-Vision
Start date: July 20, 2017
Phase:
Study type: Observational

The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities. The secondary objectives of the study are: - to validate the structure of the scale. - to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners. - to evaluate the feasibility of visio-behavioral scale. - to evaluate the sensitivity to change. - to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology). - to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.

NCT ID: NCT02980302 Completed - Healthy Volunteers Clinical Trials

Development of the Tool " iPSC " for the Functional Study of Mutations Responsible for Mental Retardation

Rementips
Start date: September 2015
Phase: N/A
Study type: Interventional

According to the World Health Organization (WHO), mental retardation (MR) is defined by an intelligence quotient (IQ) < 70 and touches between 1 to 3 % of the general population. Profound mental retardation (QI <25), severe (IQ: 25-40) and moderate (QI : 40-50) have a prevalence of 0,3-0,5% while the prevalence of mild MR, defined by an IQ between 50 and 70 is evaluated to about 1,5 %. The origin of MR can be infectious, toxic, traumatic, genetic or environmental. genetic causes of MR gather the number and structure anomalies of the chromosomes, the genomic microreorganization, monogenic diseases and more rarely other non Mendelian-inherited anomalies like print or epigenetic anomalies, mutations of the mitochondrial genome etc... Genetic causes represents 50% of moderate to severe, whereas environmental factors (malnutrition, cultural deprivation,...) plays an important role in mild MR. The main goal of this study is to get an innovative tool (neuronal distinction of iPSC) that wil allow to study the functionnal impact of mutations uppon genes probably involved in MR like MYT1L. The main criteria associated to characterisation of the tool by the trial is the study of the pluripotency of iPSC obtained and to highlight the mutation of the gene MYT1L in the iPSC. Neurons from the iPSC of the patient and his father du patient wille also be morphologically characterised, but also thanks to the expression of specifically neurals genes. Characteristics of iPSC and neurons from d'iPSC with MYT1L mutation will be compared among the patient and his father, in relation with the same cells coming from the two witnesses.

NCT ID: NCT02943304 Completed - Mental Retardation Clinical Trials

Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero

ZENI
Start date: May 1, 2016
Phase:
Study type: Observational

This prospective cohort study will determine the natural history of fetal exposure to Zika virus (ZIKV) and its effects on the fetus and newborn with emphasis on neurodevelopment outcome. Exposure of the fetus will be determined by maternal symptomatology, RT-PCR ZIKV (blood and urine) and serologic test specific for ZIKV. Neonates will be classified according to trimester of infection and as exposed and unexposed to ZIKV.

NCT ID: NCT02919826 Completed - Clinical trials for Intellectual Disability

Dialectical Behaviour Group Therapy for Adults With Intellectual Disabilities

Start date: August 2016
Phase: N/A
Study type: Interventional

To determine the feasibility and effectiveness of a RCT of an adapted DBT group delivered to individuals with ID and emotional dysregulation.